Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoxuan Zhiyun Tablets
- Development stage
- Unknown
- Lead developer
- Chongqing Kerui Pharmaceutical
- Administration
- Oral
01
Overview
Xiaoxuan Zhiyun Tablets (消眩止晕片) is a Traditional Chinese Medicine (TCM) developed and manufactured by Chongqing Kerui Pharmaceutical. It is primarily indicated for the treatment of vertigo and dizziness, particularly those resulting from liver yang hyperactivity, a pattern often associated with hypertension in TCM diagnosis. The formulation is designed to calm the liver, extinguish internal wind, and clear heat, thereby relieving symptoms such as headache, tinnitus, and blurred vision. It is administered orally in tablet form and is a multi-ingredient botanical product regulated as a pharmaceutical drug in China.
- Other names
- 消眩止晕片Xiaoxuan Zhiyun Pian
Beyond the preview
Go deeper on Xiaoxuan Zhiyun Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaoxuan Zhiyun Tablets.